Prostate cancer and novel pharmacological treatment options-what's new for 2022?
- DOI
- 10.1080/17512433.2023.2181783
- Published
- 2023 Mar
- Container
- Expert review of clinical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/17512433.2023.2181783,
title = {Prostate cancer and novel pharmacological treatment options-what's new for 2022?},
author = {Marchetti A and Tassinari E and Rosellini M and Rizzo A and Massari F and Mollica V},
year = {2023},
journal = {Expert review of clinical pharmacology},
doi = {10.1080/17512433.2023.2181783},
url = {https://doi.org/10.1080/17512433.2023.2181783}
}RIS
TY - JOUR TI - Prostate cancer and novel pharmacological treatment options-what's new for 2022? AU - Marchetti A AU - Tassinari E AU - Rosellini M AU - Rizzo A AU - Massari F AU - Mollica V PY - 2023 JO - Expert review of clinical pharmacology DO - 10.1080/17512433.2023.2181783 UR - https://doi.org/10.1080/17512433.2023.2181783 ER -
APA
A, M., E, T., M, R., A, R., F, M., & V, M. (2023). Prostate cancer and novel pharmacological treatment options-what's new for 2022?. Expert review of clinical pharmacology. https://doi.org/10.1080/17512433.2023.2181783
Source records
- pubmed · retrieved 2026-09-26T21:49:56.396Z